Original article by Anne Hyland
The Australian Financial Review – Page: 1 : 29-Jun-15
The Australian Government will subside a cancer treatment that has been credited with saving the life of businessman Ron Walker. Keytruda will be added to the list of cancer drugs that are subsidised via the Pharmaceutical Benefits Scheme, which means cancer patients will pay at most just $A37.70 to access the drug. It would previously have cost some $A150,000 per year to be treated with Keytruda. Walker had lobbied the Government to subsidise the drug.
CORPORATES
AUSTRALIA. DEPT OF HEALTH, MERCK AND COMPANY INCORPORATED, LIBERAL PARTY OF AUSTRALIA
ABIX 
My husband was in a similar situation as Ron Walker, he had secondaries in the liver spine etc. his response to Pd1 has been nothing short of a miracle. However, he suffers from severe sweating I am wondering if any other person taking PD1 has the same side effect